Prostate cancer detector Imagistx nets $4.2 mln in deal led by iGan Partners
Imagistx Inc, a Markham, Ont.-based maker of an ultra high resolution system that provides significant improvements in detecting prostate cancer, has secured a $4.2 million round of financing. The deal was led by Canadian venture capital firm iGan Partners, along with IAF, Veddis Ventures and a number of angel investors. Imagistx said it is also negotiating further commitments from major strategic investors. Proceeds of the financing will be used to conduct large-scale, multi-site clinical trials, further enhance the company's prostate ultrasound imaging system, and bring its products to market worldwide.
20 December 2013•2 mins read
